American Thought Leaders Dr. Ryan Cole: NIH Should Fund Research into Rise in Cancer
Sep 26, 2025
Dr. Ryan Cole, a board-certified pathologist and lab director, discusses alarming trends in cancer diagnoses linked to COVID-19 mRNA vaccines. He advocates for transparency in health agencies and reveals concerns about contaminants in vaccine manufacturing. Cole argues for limiting mRNA usage outside research, citing potential risks of self-amplifying technologies. He emphasizes informed consent for experimental therapies and highlights the importance of rigorous regulatory review for future vaccines. Personal anecdotes illustrate the consequences of challenging established narratives.
AI Snips
Chapters
Transcript
Episode notes
Transparency Is Shifting Public Debate
- Ryan Cole says transparency is improving and the Overton window has shifted to allow previously hidden questions to be asked.
- He argues new HHS and CDC leadership create an opportunity to expose past agency secrecy and restore public trust.
Delivery System, Not mRNA, Is Central Risk
- Cole argues the main problem with mRNA platforms is inability to target delivery, so lipid nanoparticles send mRNA throughout the body.
- He claims that makes recipient cells produce foreign proteins and become immune targets, degrading the risk-benefit profile for healthy people.
Self‑Amplifying mRNA Brings New Unknowns
- Cole warns self-amplifying mRNA has no reliable off-switch and can persist and replicate intracellularly to produce more protein.
- He worries this persistence increases mutation, shedding, and uncontrolled spread risks, calling it a potential biological disaster.